Aslıhan Alhan is an expert in Biostatistics at Ufuk University (Turkey). Aslıhan Alhan has authored 41 publications, the most recent in 2022. SLR score: 87 (community average: 125). How the SLR is computed.

LeadR Profile

Aslıhan Alhan Ufuk University Turkey
87 ScienceLeadR Reputation 87
Network Map

Biostatistics

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026

Source: PubMed

Independent Researcher

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 41

Citations

Citations: 487 1st author: 0 Last author: 10 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Possible predictive clinical and radiological markers in decision making for surgical intervention in patients with Chiari Malformation type 1.
PMID 35758154 — risk, decision making
Neurol Res20224
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR).
PMID 34308869 — receptors, angiotensin, hospitalization, heart failure, heart, cardiovascular diseases, neprilysin, angiotensins, heart failure, systolic
Turk Kardiyol Dern Ars202112
Inactive SARS-COV-2 Vaccine Adverse Effects Among Hospital Workers
OpenAlex W3206348990 — sars-cov-2, vaccines, covid-19 vaccines, severe acute respiratory syndrome-related coronavirus
Journal of international health sciences and management20210
AVERAGE GLANDULAR DOSES AND NATIONAL DIAGNOSTIC REFERENCE LEVELS IN MAMMOGRAPHY EXAMINATIONS IN TURKEY.
PMID 32556186 — skin, diagnostic reference levels, mammography, radiation monitoring, air, breast, radiation protection
Radiat Prot Dosimetry202023
In spontaneous intracerebral hematoma patients, prediction of the hematoma expansion risk and mortality risk using radiological and clinical markers and a newly developed scale.
PMID 33402048 — mortality, risk, prognosis, hematoma
Neurol Res20217

LeadR Networks

Main global connection map